Sex and age linked to blood protein levels in older Congolese adults
The observational study of 786 adults aged 65 or older also found that sex and age were strongly linked to blood protein levels.
Limit: Biomarker selection used the full dataset before cross-validation, potentially inflating model performance
Edited by Boris Djordjevic · AgingResearch.News
Researchers measured blood proteins in an observational study of 786 adults aged 65 or older in Kinshasa, Democratic Republic of the Congo. Participants ranged from people without cognitive impairment—problems with memory or thinking—to those with mild impairment or dementia. Sex had the strongest associations with protein levels, followed by age. MME, a protein measured in blood, was lower across all dementia groups than among participants without cognitive impairment.
A model combined 10 blood markers with age, sex and whether participants carried APOE ε4, a genetic variant. In repeated internal testing, its average area under the curve—a measure of how well it distinguished groups—was 0.768, compared with 0.612 for brain-derived pTau217, a modified form of the tau protein, alone. The findings supported demographic adjustment and population-specific validation of blood markers.
Why it matters
Blood markers for Alzheimer disease and related dementias have been validated largely in populations of European ancestry. This work addresses how to interpret such markers in older adults from other populations.
Caveats
The model’s performance may be overestimated because researchers selected and ranked markers using the full dataset before internal testing. This observational preprint has not been peer-reviewed; the authors identified MME as a signal for further study.
The paper
Emory University; University of Pittsburgh
medRxiv, Oct 28, 2026, Open access, Preprint, not peer-reviewed
